Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vy Broadbridge

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Diagnosis & Therapy|December 16, 2021
Targeting Mutated KRAS Genes to Treat Solid TumoursTharani Krishnan, Rachel Roberts-Thomson, Vy Broadbridge, et al.
BMJ Case Reports|November 5, 2011
Contrast induced hyperthyroidism due to iodine excessUsman Mushtaq, Timothy Price, Narsing Laddipeerla, et al.
British Journal of Cancer|March 9, 2022
Immunotherapy use in oesophagogastric cancers-a review of the literatureAnnabel Smith, Amitesh Roy, Christos S Karapetis, et al.
The Australian Journal of Rural Health|October 11, 2014
Rural populations have equal surgical and survival outcomes in metastatic colorectal cancerApresh Singla, Vy Broadbridge, Murthy Mittinty, et al.
Drugs & Aging|February 16, 2017
Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the EvidenceGonzalo Tapia Rico, Amanda R Townsend, Vy Broadbridge, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2022
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 studyAndrew Dean, Sanjeev Gill, Mark McGregor, et al.
World Journal of Gastrointestinal Oncology|August 28, 2018
Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?Rachael Chang Lee, Harsh Kanhere, Markus Trochsler, et al.
Journal of Clinical Gastroenterology|May 11, 2010
Reversing Hyperammonemia in Neuroendocrine TumorsVy Broadbridge, Amanda Townsend, Kenneth Pittman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2013
A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancerSina Vatandoust, Rohit Joshi, Kenneth B Pittman, et al.
American Journal of Clinical Oncology|January 25, 2012
Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapyAmanda R Townsend, Sarwan Bishnoi, Vy Broadbridge, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Diagnosis & Therapy|December 16, 2021
Targeting Mutated KRAS Genes to Treat Solid TumoursTharani Krishnan, Rachel Roberts-Thomson, Vy Broadbridge, et al.
BMJ Case Reports|November 5, 2011
Contrast induced hyperthyroidism due to iodine excessUsman Mushtaq, Timothy Price, Narsing Laddipeerla, et al.
British Journal of Cancer|March 9, 2022
Immunotherapy use in oesophagogastric cancers-a review of the literatureAnnabel Smith, Amitesh Roy, Christos S Karapetis, et al.
The Australian Journal of Rural Health|October 11, 2014
Rural populations have equal surgical and survival outcomes in metastatic colorectal cancerApresh Singla, Vy Broadbridge, Murthy Mittinty, et al.
Drugs & Aging|February 16, 2017
Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the EvidenceGonzalo Tapia Rico, Amanda R Townsend, Vy Broadbridge, et al.
The Lancet. Gastroenterology & Hepatology|July 8, 2022
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 studyAndrew Dean, Sanjeev Gill, Mark McGregor, et al.
World Journal of Gastrointestinal Oncology|August 28, 2018
Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?Rachael Chang Lee, Harsh Kanhere, Markus Trochsler, et al.
Journal of Clinical Gastroenterology|May 11, 2010
Reversing Hyperammonemia in Neuroendocrine TumorsVy Broadbridge, Amanda Townsend, Kenneth Pittman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 15, 2013
A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancerSina Vatandoust, Rohit Joshi, Kenneth B Pittman, et al.
American Journal of Clinical Oncology|January 25, 2012
Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapyAmanda R Townsend, Sarwan Bishnoi, Vy Broadbridge, et al.
Pageof 2